AYNI GLA LIMITED
Opportunity 70/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (71/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2024-09-30 |
|---|---|
| Total assets | £-3.6k |
| Cash | £30 |
| Net assets | £-3.6k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (7 events)Click to expand
- 2025-01-21📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-10-31➖NAKHUDA, Hafsah resigneddirector
- 2023-10-31📄termination-director-company-with-name-termination-dateofficers · TM01
- 2023-09-19🏢Company incorporatedAs AYNI GLA LIMITED
- 2023-09-19➕DESAI, Mohammed Abrar Ebrahim appointeddirector
- 2023-09-19➕NAKHUDA, Hafsah appointeddirector
- 2023-09-19📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 2.6 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mrs Hafsah Nakhuda Individual · British · DOB 03/2002 · age 24 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 19/09/2023 |
Mr Mohammed Abrar Ebrahim Desai Individual · British · DOB 01/1996 · age 30 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 19/09/2023 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AR DENTAL LIMITED→ SC400032 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| ARDPEATON LIMITED→ SC780810 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ARICOM SATELLITE LIMITED→ SC678887 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ARRAN PHARMACY LIMITED→ SC222920 · est 2001 · no financials extracted | — | — | — | — | 24y | — | — |
| ASHPHARM GLASGOW LTD→ SC628555 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AURORA WOMEN'S MEDICAL LTD→ SC881744 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AVISTAR MEDICAL LTD→ SC864683 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AWSC LIMITED→ SC636346 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AXON PAIN CLINICS LIMITED→ SC782268 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AYMAN & MARTIN LIMITED→ SC723846 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| AYPLUS MEDICS LIMITED→ SC792280 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AYR CARE LTD→ SC665188 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 1 resigned)
Click a director name to see their full track record across all companies.